Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22741162 | 0.94 | — | — | |
| SCHEMBL22743357 | 0.91 | — | — | |
| SCHEMBL22741502 | 0.90 | — | — | |
| SCHEMBL22741466 | 0.90 | — | — | |
| SCHEMBL22741551 | 0.89 | ESR1 (0.32) | — | |
| SCHEMBL22741565 | 0.89 | — | — | |
| SCHEMBL22741503 | 0.89 | — | — | |
| SCHEMBL22741500 | 0.88 | — | — | |
| SCHEMBL22740622 | 0.88 | ESR1 (0.32) | — | |
| SCHEMBL22742630 | 0.87 | HDAC8 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, TMEM109, LEF1 | CYP26A1 2736/4885CYP26B1 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.